Trial Profile
The Utility of in Vivo Confocal Microscopy (IVCM) to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease (DED)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate (Primary)
- Indications Dry eyes
- Focus Pharmacodynamics
- 24 Feb 2022 The primary endpoints have been changed to IVCM for Density of Corneal Immune Dendritiform Cells (2 and 6 weeks) and IVCM for Corneal Immune Dendritiform Cell (DC) Morphology (2 and 6 weeks), according to ClinicalTrials.gov record.
- 29 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Jul 2014 New trial record